#CovidVaccine #VaccinationDrive
India has approved two vaccines for emergency public rollout. As this process unfolds, there are questions that need answering - questions about the vaccines, the approvals, the data, among other things.
To understand all the yin and yang of India’s vaccines, Health Analytics Asia spoke to one of India’s top virologists Dr. Shahid Jameel. Presently Director of the Trivedi School of Biosciences at Ashoka University, he has served as the CEO of Wellcome Trust-DBT Alliance for over seven years.
For more information visit our websites :
[ Ссылка ]
[ Ссылка ]
Credits:
Edited & Produced: Hashim Ahmad Hakeem
IN CONVERSATION WITH | Dr. Shahid Jameel
Теги
COVID19Coronavirus vaccineIndia vaccineSerum InstituteBharat BiotechCovishieldCovaxinPfizerModernavaccine trialsvaccine efficacyICMRclinical trialHyderabadvaccinationtrial datashahid jameelvirologistdr. shahid jameelashoka universitywellcome trustdbt alliancevaccine newsindia vaccine newscoronacovid strainINSACOGIndia’s Genome Sequencing ConsortiumSenior virologistcongressbjpRenu SwarupThe New York Timesdelhiindia govt
